Eustachian Tube Dysfunction: Evidence and Controversies (2023 AMW)
2023 AAO-HNSF Annual Meeting & OTO Experience
Keyword(s)
Eustachian tube dysfunction
PROGRAM DESCRIPTION: Eustachian tube dysfunction is a common diagnosis in general otolaryngology practice. A growing body of evidence suggests the need for a multifactorial evaluation when this diagnosis is being considered, and various options for treatment are available for which the indications and effectiveness continue to be defined. This panel presentation will provide an overview of the currently available evidence related to the diagnosis and management of adult Eustachian tube dysfunction. Presentations will synthesize available knowledge, drawing upon statements from the AAO-HNSF Clinical Consensus Statement. Discussion will feature expert opinions from a well-versed panel, with representation by otologists and rhinologists to provide a balanced perspective of the topic.OUTCOME OBJECTIVE 1: Understand the diagnostic evaluation of adult Eustachian tube dysfunction.OUTCOME OBJECTIVE 2: Appreciate current areas of consensus in the management of adult Eustachian tube dysfunction.OUTCOME OBJECTIVE 3: Recognize where experts agree and disagree regarding the indications for treating adult Eustachian tube dysfunction.BACKGROUND STATEMENT: There is a need for clinicians to understand the evidence supporting the diagnosis and management of patients with Eustachian tube dysfunction, as new technology and procedure codes are introduced for the treatment of this condition.
Credits
CME:1.0, MOC:1.0
Description
Eustachian tube dysfunction is a common diagnosis in general otolaryngology practice. A growing body of evidence suggests the need for a multifactorial evaluation when this diagnosis is being considered, and various options for treatment are available for which the indications and effectiveness continue to be defined. This panel presentation will provide an overview of the currently available evidence related to the diagnosis and management of adult Eustachian tube dysfunction. Presentations will synthesize available knowledge, drawing upon statements from the recent AAO-HNSF Clinical Consensus Statement. Discussion will feature expert opinions from a well-versed panel, with equal representation by otologists and rhinologists to provide a balanced perspective of the topic. Learning Objectives: 1. Explain the diagnostic evaluation of adult Eustachian tube dysfunction. 2. Summarize current areas of consensus in the management of adult Eustachian tube dysfunction. 3. Recognize where experts agree and disagree regarding the indications for treating adult Eustachian tube dysfunction.Faculty: Edward McCoul, MD(Honoraria: Acclarent; Consulting Fees: Acclarent), Dennis Poe, MD, PhD( Other: Karl Storz; Consulting Fees: Acclarent), Michael Setzen, MD FACS FAAP(Expert Witness Defense: Medical Liability case; Honoraria: Meda; Consulting Fees: Lannett; Arrinex-Consultant), William Slattery, MD(Intellectual Property Rights: Cochlear Corporation; Stock or Stock Options: O-Ray Pharma; Salary: House Ear Clinic; O-Ray Pharma; Honoraria: Cochlear Corporation; Alcon), Raj Sindwani, MD, FRCSC(Honoraria: Sage Publications; Leadership Role: Sage Publications; Consulting Fees: Olympus; Acclarent; Medtronic).